Liver Disease News and Research

RSS
Natural PLA2 inhibitor from marine fungus combats fatty liver disease by silencing lipotoxic pathways

Natural PLA2 inhibitor from marine fungus combats fatty liver disease by silencing lipotoxic pathways

Exploring the link between pancreatic islet cell loss and age-related health conditions

Exploring the link between pancreatic islet cell loss and age-related health conditions

Groundbreaking study uncovers hundreds of genetic markers linked to insulin resistance

Groundbreaking study uncovers hundreds of genetic markers linked to insulin resistance

Extended liver preservation technique shows promise for daytime transplants

Extended liver preservation technique shows promise for daytime transplants

mRNA therapy shows promise for curing children's rare liver disease

mRNA therapy shows promise for curing children's rare liver disease

New imaging technique could transform diagnosis and treatment of steatotic liver disease

New imaging technique could transform diagnosis and treatment of steatotic liver disease

£30M clinical study will enhance the understanding of NASH cirrhosis

£30M clinical study will enhance the understanding of NASH cirrhosis

Revolutionary study reveals Lactobacillus acidophilus could ward off liver cancer linked to fatty liver disease

Revolutionary study reveals Lactobacillus acidophilus could ward off liver cancer linked to fatty liver disease

Combining ezetimibe and bempedoic acid effectively lowers cholesterol in statin-intolerant patients

Combining ezetimibe and bempedoic acid effectively lowers cholesterol in statin-intolerant patients

New app helps patients with alcohol-related liver disease recover, saves lives

New app helps patients with alcohol-related liver disease recover, saves lives

Gut microbes revealed as key players in liver disease solutions

Gut microbes revealed as key players in liver disease solutions

CLivD score shows promise in early detection of steatotic liver disease and advanced fibrosis

CLivD score shows promise in early detection of steatotic liver disease and advanced fibrosis

Exploring the global health challenge of hepatitis D

Exploring the global health challenge of hepatitis D

New non-steroidal anti-inflammatory can inhibit the cytokine storm and preserve innate immunity

New non-steroidal anti-inflammatory can inhibit the cytokine storm and preserve innate immunity

From diabetes drug to anti-inflammation powerhouse: The unexpected evolution of GLP-1

From diabetes drug to anti-inflammation powerhouse: The unexpected evolution of GLP-1

Study shows synergistic effects of genetic factors, binge drinking, and diabetes in alcohol-related cirrhosis

Study shows synergistic effects of genetic factors, binge drinking, and diabetes in alcohol-related cirrhosis

Science’s Breakthrough of the Year: GLP-1 agonists can blunt obesity-associated health problems

Science’s Breakthrough of the Year: GLP-1 agonists can blunt obesity-associated health problems

Study points to binge drinking and genetics as key factors in liver disease

Study points to binge drinking and genetics as key factors in liver disease

Study finds key gene deletion shields mice from diet-induced obesity and liver disease

Study finds key gene deletion shields mice from diet-induced obesity and liver disease

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.